nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—MAOA—Parkinson's disease	0.445	0.57	CbGaD
Rizatriptan—HTR1A—Parkinson's disease	0.337	0.43	CbGaD
Rizatriptan—MAOA—locus ceruleus—Parkinson's disease	0.00735	0.114	CbGeAlD
Rizatriptan—HTR1B—telencephalic ventricle—Parkinson's disease	0.00472	0.0736	CbGeAlD
Rizatriptan—HTR1D—telencephalic ventricle—Parkinson's disease	0.00457	0.0712	CbGeAlD
Rizatriptan—HTR1A—telencephalic ventricle—Parkinson's disease	0.00381	0.0594	CbGeAlD
Rizatriptan—HTR1F—forebrain—Parkinson's disease	0.00301	0.0469	CbGeAlD
Rizatriptan—MAOA—nerve—Parkinson's disease	0.0022	0.0342	CbGeAlD
Rizatriptan—Melatonin—NQO2—Parkinson's disease	0.00186	0.243	CrCbGaD
Rizatriptan—HTR1A—hindbrain—Parkinson's disease	0.0018	0.028	CbGeAlD
Rizatriptan—HTR1F—head—Parkinson's disease	0.00172	0.0269	CbGeAlD
Rizatriptan—MAOA—hindbrain—Parkinson's disease	0.00164	0.0256	CbGeAlD
Rizatriptan—HTR1F—nervous system—Parkinson's disease	0.00163	0.0255	CbGeAlD
Rizatriptan—HTR1F—central nervous system—Parkinson's disease	0.00157	0.0245	CbGeAlD
Rizatriptan—HTR1B—brainstem—Parkinson's disease	0.00128	0.0199	CbGeAlD
Rizatriptan—HTR1F—brain—Parkinson's disease	0.00125	0.0195	CbGeAlD
Rizatriptan—HTR1D—brainstem—Parkinson's disease	0.00124	0.0193	CbGeAlD
Rizatriptan—HTR1B—forebrain—Parkinson's disease	0.00123	0.0192	CbGeAlD
Rizatriptan—HTR1D—forebrain—Parkinson's disease	0.00119	0.0186	CbGeAlD
Rizatriptan—Zolmitriptan—MAOA—Parkinson's disease	0.00109	0.143	CrCbGaD
Rizatriptan—HTR1B—cardiovascular system—Parkinson's disease	0.00104	0.0162	CbGeAlD
Rizatriptan—HTR1A—brainstem—Parkinson's disease	0.00103	0.0161	CbGeAlD
Rizatriptan—MAOA—embryo—Parkinson's disease	0.00103	0.016	CbGeAlD
Rizatriptan—HTR1D—cardiovascular system—Parkinson's disease	0.00101	0.0157	CbGeAlD
Rizatriptan—HTR1A—forebrain—Parkinson's disease	0.000996	0.0155	CbGeAlD
Rizatriptan—MAOA—brainstem—Parkinson's disease	0.000942	0.0147	CbGeAlD
Rizatriptan—MAOA—forebrain—Parkinson's disease	0.00091	0.0142	CbGeAlD
Rizatriptan—HTR1A—cardiovascular system—Parkinson's disease	0.000842	0.0131	CbGeAlD
Rizatriptan—Almotriptan—MAOA—Parkinson's disease	0.000828	0.108	CrCbGaD
Rizatriptan—Zolmitriptan—HTR1A—Parkinson's disease	0.000825	0.108	CrCbGaD
Rizatriptan—HTR1B—midbrain—Parkinson's disease	0.000815	0.0127	CbGeAlD
Rizatriptan—Sumatriptan—MAOA—Parkinson's disease	0.000797	0.104	CrCbGaD
Rizatriptan—HTR1B—spinal cord—Parkinson's disease	0.000795	0.0124	CbGeAlD
Rizatriptan—HTR1D—midbrain—Parkinson's disease	0.000789	0.0123	CbGeAlD
Rizatriptan—MAOA—cardiovascular system—Parkinson's disease	0.000769	0.012	CbGeAlD
Rizatriptan—HTR1B—head—Parkinson's disease	0.000706	0.011	CbGeAlD
Rizatriptan—HTR1D—head—Parkinson's disease	0.000684	0.0107	CbGeAlD
Rizatriptan—HTR1B—nervous system—Parkinson's disease	0.00067	0.0104	CbGeAlD
Rizatriptan—HTR1A—midbrain—Parkinson's disease	0.000657	0.0102	CbGeAlD
Rizatriptan—MAOA—medulla oblongata—Parkinson's disease	0.000657	0.0102	CbGeAlD
Rizatriptan—HTR1D—nervous system—Parkinson's disease	0.000648	0.0101	CbGeAlD
Rizatriptan—HTR1B—central nervous system—Parkinson's disease	0.000645	0.01	CbGeAlD
Rizatriptan—HTR1A—spinal cord—Parkinson's disease	0.000641	0.00999	CbGeAlD
Rizatriptan—HTR1D—central nervous system—Parkinson's disease	0.000624	0.00972	CbGeAlD
Rizatriptan—Sumatriptan—HTR1A—Parkinson's disease	0.000602	0.0786	CrCbGaD
Rizatriptan—MAOA—midbrain—Parkinson's disease	0.000601	0.00935	CbGeAlD
Rizatriptan—MAOA—spinal cord—Parkinson's disease	0.000586	0.00913	CbGeAlD
Rizatriptan—HTR1A—head—Parkinson's disease	0.00057	0.00888	CbGeAlD
Rizatriptan—HTR1A—nervous system—Parkinson's disease	0.00054	0.00842	CbGeAlD
Rizatriptan—MAOA—head—Parkinson's disease	0.000521	0.00811	CbGeAlD
Rizatriptan—HTR1A—central nervous system—Parkinson's disease	0.00052	0.0081	CbGeAlD
Rizatriptan—HTR1B—brain—Parkinson's disease	0.000512	0.00797	CbGeAlD
Rizatriptan—Sumatriptan—DRD2—Parkinson's disease	0.000511	0.0667	CrCbGaD
Rizatriptan—Almotriptan—CYP2E1—Parkinson's disease	0.000511	0.0667	CrCbGaD
Rizatriptan—HTR1A—cerebellum—Parkinson's disease	0.000509	0.00792	CbGeAlD
Rizatriptan—HTR1D—brain—Parkinson's disease	0.000496	0.00772	CbGeAlD
Rizatriptan—MAOA—nervous system—Parkinson's disease	0.000494	0.00769	CbGeAlD
Rizatriptan—MAOA—central nervous system—Parkinson's disease	0.000475	0.0074	CbGeAlD
Rizatriptan—MAOA—cerebellum—Parkinson's disease	0.000465	0.00724	CbGeAlD
Rizatriptan—HTR1A—brain—Parkinson's disease	0.000413	0.00643	CbGeAlD
Rizatriptan—MAOA—brain—Parkinson's disease	0.000377	0.00588	CbGeAlD
Rizatriptan—Almotriptan—CYP2D6—Parkinson's disease	0.000375	0.049	CrCbGaD
Rizatriptan—Sumatriptan—ABCB1—Parkinson's disease	0.000258	0.0337	CrCbGaD
Rizatriptan—HTR1D—Signaling Pathways—RIT2—Parkinson's disease	5.25e-05	0.000359	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.24e-05	0.000358	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—EDN1—Parkinson's disease	5.24e-05	0.000358	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.23e-05	0.000357	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—HTR2A—Parkinson's disease	5.19e-05	0.000354	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADORA2A—Parkinson's disease	5.18e-05	0.000354	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RIT2—Parkinson's disease	5.14e-05	0.000351	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	5.08e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—HTR2A—Parkinson's disease	5.08e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADORA2A—Parkinson's disease	5.07e-05	0.000346	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	5e-05	0.000342	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GRK5—Parkinson's disease	4.97e-05	0.00034	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HTR1A—Parkinson's disease	4.95e-05	0.000338	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGF20—Parkinson's disease	4.93e-05	0.000337	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	4.9e-05	0.000335	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	4.9e-05	0.000335	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	4.88e-05	0.000334	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—TAC1—Parkinson's disease	4.87e-05	0.000333	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GRK5—Parkinson's disease	4.87e-05	0.000333	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	4.85e-05	0.000331	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—HTR1A—Parkinson's disease	4.84e-05	0.000331	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADORA2A—Parkinson's disease	4.78e-05	0.000327	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD1—Parkinson's disease	4.78e-05	0.000326	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—TAC1—Parkinson's disease	4.77e-05	0.000326	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EDN1—Parkinson's disease	4.76e-05	0.000325	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD1—Parkinson's disease	4.68e-05	0.00032	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD3—Parkinson's disease	4.63e-05	0.000316	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—HTR2A—Parkinson's disease	4.58e-05	0.000313	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	4.54e-05	0.00031	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD3—Parkinson's disease	4.53e-05	0.00031	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR1A—Parkinson's disease	4.49e-05	0.000307	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.49e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	4.48e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GRM4—Parkinson's disease	4.46e-05	0.000305	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—TAC1—Parkinson's disease	4.42e-05	0.000302	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	4.42e-05	0.000302	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—INSR—Parkinson's disease	4.41e-05	0.000302	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HTR1A—Parkinson's disease	4.4e-05	0.000301	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—COMT—Parkinson's disease	4.4e-05	0.0003	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	4.39e-05	0.0003	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	4.39e-05	0.0003	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	4.37e-05	0.000299	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GRM4—Parkinson's disease	4.37e-05	0.000299	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	4.36e-05	0.000298	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD1—Parkinson's disease	4.34e-05	0.000296	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	4.33e-05	0.000296	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—TAC1—Parkinson's disease	4.33e-05	0.000296	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.32e-05	0.000295	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	4.31e-05	0.000295	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—DDC—Parkinson's disease	4.3e-05	0.000294	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.25e-05	0.000291	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD1—Parkinson's disease	4.25e-05	0.00029	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.23e-05	0.000289	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAG—Parkinson's disease	4.23e-05	0.000289	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PENK—Parkinson's disease	4.23e-05	0.000289	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD3—Parkinson's disease	4.2e-05	0.000287	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HTR7—Parkinson's disease	4.18e-05	0.000286	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—DRD2—Parkinson's disease	4.18e-05	0.000286	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGB—Parkinson's disease	4.17e-05	0.000285	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HTR2A—Parkinson's disease	4.16e-05	0.000284	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR1A—Parkinson's disease	4.15e-05	0.000284	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAG—Parkinson's disease	4.14e-05	0.000283	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PENK—Parkinson's disease	4.14e-05	0.000283	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD3—Parkinson's disease	4.11e-05	0.000281	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—HTR7—Parkinson's disease	4.1e-05	0.00028	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—DRD2—Parkinson's disease	4.1e-05	0.00028	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TAC1—Parkinson's disease	4.09e-05	0.000279	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTA4—Parkinson's disease	4.06e-05	0.000277	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	4.02e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD1—Parkinson's disease	4.01e-05	0.000274	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	3.96e-05	0.000271	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRBK1—Parkinson's disease	3.92e-05	0.000268	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	3.91e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD3—Parkinson's disease	3.88e-05	0.000265	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PDYN—Parkinson's disease	3.87e-05	0.000264	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	3.87e-05	0.000264	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	3.86e-05	0.000264	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRBK1—Parkinson's disease	3.84e-05	0.000262	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.81e-05	0.000261	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR7—Parkinson's disease	3.8e-05	0.00026	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—DRD2—Parkinson's disease	3.8e-05	0.00026	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PDYN—Parkinson's disease	3.79e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—DRD2—Parkinson's disease	3.72e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HTR7—Parkinson's disease	3.72e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	3.71e-05	0.000254	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PLA2G6—Parkinson's disease	3.66e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GFAP—Parkinson's disease	3.64e-05	0.000249	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	3.63e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRBK1—Parkinson's disease	3.62e-05	0.000248	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.62e-05	0.000247	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MAOB—Parkinson's disease	3.62e-05	0.000247	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GRM5—Parkinson's disease	3.6e-05	0.000246	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	3.56e-05	0.000243	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GFAP—Parkinson's disease	3.56e-05	0.000243	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GRM5—Parkinson's disease	3.52e-05	0.000241	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR7—Parkinson's disease	3.51e-05	0.00024	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DRD2—Parkinson's disease	3.51e-05	0.00024	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	3.45e-05	0.000236	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—EDN1—Parkinson's disease	3.35e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	3.33e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	3.3e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—EDN1—Parkinson's disease	3.28e-05	0.000224	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	3.24e-05	0.000221	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.22e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PENK—Parkinson's disease	3.15e-05	0.000216	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAG—Parkinson's disease	3.15e-05	0.000216	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF20—Parkinson's disease	3.15e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	3.13e-05	0.000214	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	3.12e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	3.12e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF20—Parkinson's disease	3.09e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.08e-05	0.00021	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADORA2A—Parkinson's disease	3.06e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EDN1—Parkinson's disease	3.04e-05	0.000208	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.03e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADORA2A—Parkinson's disease	2.99e-05	0.000205	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EDN1—Parkinson's disease	2.98e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF2—Parkinson's disease	2.94e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HTR2A—Parkinson's disease	2.93e-05	0.0002	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.93e-05	0.0002	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	2.89e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	2.87e-05	0.000196	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MCCC1—Parkinson's disease	2.85e-05	0.000195	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ND3—Parkinson's disease	2.85e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1R—Parkinson's disease	2.84e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.83e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.83e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INSR—Parkinson's disease	2.82e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EDN1—Parkinson's disease	2.81e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INSR—Parkinson's disease	2.76e-05	0.000189	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	2.71e-05	0.000185	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP2D6—Parkinson's disease	2.69e-05	0.000184	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	2.68e-05	0.000183	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—OMD—Parkinson's disease	2.68e-05	0.000183	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TALDO1—Parkinson's disease	2.68e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGB—Parkinson's disease	2.67e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR2A—Parkinson's disease	2.66e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR1A—Parkinson's disease	2.65e-05	0.000181	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CTGF—Parkinson's disease	2.64e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	2.61e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGB—Parkinson's disease	2.61e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	2.61e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	2.6e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NGF—Parkinson's disease	2.58e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	2.56e-05	0.000175	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	2.56e-05	0.000175	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.54e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	2.51e-05	0.000171	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.5e-05	0.000171	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	2.48e-05	0.00017	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP2E1—Parkinson's disease	2.46e-05	0.000168	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR2A—Parkinson's disease	2.46e-05	0.000168	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NQO1—Parkinson's disease	2.43e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	2.43e-05	0.000166	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.42e-05	0.000166	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TH—Parkinson's disease	2.4e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	2.35e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	2.32e-05	0.000158	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYCS—Parkinson's disease	2.3e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—APOE—Parkinson's disease	2.29e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.28e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	2.27e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	2.27e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	2.24e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	2.24e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	2.2e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	2.2e-05	0.00015	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.19e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.19e-05	0.000149	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GBA—Parkinson's disease	2.16e-05	0.000148	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—DBH—Parkinson's disease	2.16e-05	0.000148	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.16e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INSR—Parkinson's disease	2.11e-05	0.000144	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—COMT—Parkinson's disease	2.04e-05	0.000139	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTP1—Parkinson's disease	2.03e-05	0.000139	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HMOX1—Parkinson's disease	2e-05	0.000137	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.99e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.98e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—INS—Parkinson's disease	1.95e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.95e-05	0.000133	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCB1—Parkinson's disease	1.92e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.91e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	1.88e-05	0.000129	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTM1—Parkinson's disease	1.86e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.85e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.84e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	1.82e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	1.8e-05	0.000123	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GPX1—Parkinson's disease	1.79e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.78e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.76e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.73e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.67e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.67e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGF—Parkinson's disease	1.65e-05	0.000113	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—Parkinson's disease	1.65e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.62e-05	0.00011	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—DDC—Parkinson's disease	1.59e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	1.57e-05	0.000107	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.54e-05	0.000105	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—Parkinson's disease	1.53e-05	0.000105	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.5e-05	0.000102	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.48e-05	0.000101	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—Parkinson's disease	1.46e-05	9.99e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	1.45e-05	9.93e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	1.44e-05	9.87e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1.43e-05	9.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.4e-05	9.59e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.36e-05	9.27e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.35e-05	9.21e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.34e-05	9.16e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	1.34e-05	9.13e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.33e-05	9.12e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—INS—Parkinson's disease	1.31e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.27e-05	8.68e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INS—Parkinson's disease	1.25e-05	8.53e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.23e-05	8.42e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INS—Parkinson's disease	1.22e-05	8.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.17e-05	8.01e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—Parkinson's disease	1.09e-05	7.45e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	9.92e-06	6.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CTGF—Parkinson's disease	9.74e-06	6.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INS—Parkinson's disease	9.31e-06	6.36e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	9.3e-06	6.35e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	9.23e-06	6.31e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	9.1e-06	6.22e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	9.07e-06	6.2e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	9.04e-06	6.18e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NQO1—Parkinson's disease	8.97e-06	6.13e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TH—Parkinson's disease	8.84e-06	6.04e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	8.54e-06	5.84e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—Parkinson's disease	8.53e-06	5.83e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYCS—Parkinson's disease	8.49e-06	5.8e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	8.36e-06	5.72e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—COMT—Parkinson's disease	7.52e-06	5.14e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—Parkinson's disease	7.48e-06	5.11e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MAOA—Parkinson's disease	7.46e-06	5.1e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—Parkinson's disease	7.38e-06	5.04e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—Parkinson's disease	7.08e-06	4.84e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	6.93e-06	4.74e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	6.89e-06	4.71e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—Parkinson's disease	6.87e-06	4.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—Parkinson's disease	6.58e-06	4.5e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	6.37e-06	4.35e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—Parkinson's disease	6.08e-06	4.15e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—Parkinson's disease	5.66e-06	3.87e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—Parkinson's disease	5.46e-06	3.73e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—Parkinson's disease	5.34e-06	3.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—INS—Parkinson's disease	4.83e-06	3.3e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—Parkinson's disease	4.07e-06	2.78e-05	CbGpPWpGaD
